Working groups
Angus is a research assistant in the Burnet Diagnostics Initiative (BDI). He is passionate about disease elimination, novel therapeutic treatments, and developing point of care tests. Angus has worked in the diagnostic sector for several years with infectious disease relating to both human (SARS CoV-2, Bacteroides sp., JEV), and animal health (FMD, LSD, BVD).
Angus’ MSc in the Department of Microbiology, Anatomy, Physiology, and Pharmacology (MAPP) at La Trobe University examined the immune mechanisms and susceptibility of Australian molluscs following viral challenge.
Watson A, Agius J, Ackerly D, Beddoe T, Helbig K. The Role of Anti-Viral Effector Molecules in Mollusc Hemolymph. 2022 Feb 23;12(3):345. doi: 10.3390/biom12030345. PMID: 35327536; PMCID: PMC8945852.
Watson A. Examining the Immune Mechanisms and Susceptibility of Abalone Following Viral Challenge. 2023 Jul 12. Thesis
bioRxiv (Cold Spring Harbor Laboratory)
Angus C Watson
Figshare
Angus C Watson
Biomolecules
Angus C Watson
We’re developing a novel class of antibody and delivery technologies to provide enhanced protection and therapeutic performance for coronaviruses and other respiratory infections.
A rapid point-of-care (POC) test for liver disease biomarkers could improve the management of acute and chronic liver disease and reduce the progression to liver cancer in Australia and globally.
We're developing point-of-care diagnostics for active syphilis, aiming to transform syphilis management globally and contribute to World Health Organization goals.